biospecimen_aliquot__bcr_aliquot_barcode	tcga-a1-a0se-01a-11d-a099-09
biospecimen_aliquot__bcr_aliquot_uuid	0539776c-3943-41d0-972c-8dc833a603e5
biospecimen_aliquot__bcr_patient_uuid	c397e6c2-ba3a-4f5e-a258-c140611192fe
biospecimen_aliquot__bcr_sample_barcode	tcga-a1-a0se-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100475489
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2010-10-12
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	3
biospecimen_aliquot__plate_id	a099
biospecimen_aliquot__plate_row	f
biospecimen_aliquot__quantity	2.08
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	2.00
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-a1-a0se-01a-11d
biospecimen_analyte__bcr_analyte_uuid	c40059b4-74f3-4f09-a59b-12ccdd4c4d19
biospecimen_analyte__bcr_patient_uuid	c397e6c2-ba3a-4f5e-a258-c140611192fe
biospecimen_analyte__bcr_sample_barcode	tcga-a1-a0se-01a
biospecimen_analyte__concentration	0.15
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-a1-a0se
biospecimen_diagnostic_slides__bcr_patient_uuid	c397e6c2-ba3a-4f5e-a258-c140611192fe
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-a1-a0se-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	04b09232-c6c4-46ef-aa2c-41d078d0a80a
biospecimen_normal_control__bcr_patient_barcode	tcga-a1-a0se
biospecimen_normal_control__bcr_patient_uuid	c397e6c2-ba3a-4f5e-a258-c140611192fe
biospecimen_portion__bcr_patient_uuid	c397e6c2-ba3a-4f5e-a258-c140611192fe
biospecimen_portion__bcr_portion_barcode	tcga-a1-a0se-01a-11
biospecimen_portion__bcr_portion_uuid	69f5731d-02ac-40c3-91fd-c2399740c16e
biospecimen_portion__bcr_sample_barcode	tcga-a1-a0se-01a
biospecimen_portion__date_of_creation	2010-07-29
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-a1-a0se-01a-11d
biospecimen_protocol__bcr_patient_uuid	c397e6c2-ba3a-4f5e-a258-c140611192fe
biospecimen_protocol__bcr_sample_barcode	tcga-a1-a0se-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	c397e6c2-ba3a-4f5e-a258-c140611192fe
biospecimen_sample__bcr_sample_barcode	tcga-a1-a0se-01a
biospecimen_sample__bcr_sample_uuid	2fd1998c-1ea4-42eb-84b9-db352da9cf25
biospecimen_sample__days_to_collection	1672
biospecimen_sample__initial_weight	90
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-a1-a0se.cff567fc-8867-4ca4-85ae-81a7d30095e7.pdf
biospecimen_sample__pathology_report_uuid	cff567fc-8867-4ca4-85ae-81a7d30095e7
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_slide__bcr_patient_uuid	c397e6c2-ba3a-4f5e-a258-c140611192fe
biospecimen_slide__bcr_sample_barcode	tcga-a1-a0se-01a
biospecimen_slide__bcr_slide_barcode	tcga-a1-a0se-01a-01-bs1
biospecimen_slide__bcr_slide_uuid	bc41fb6d-f6a5-495c-b429-80d289f0bda1
biospecimen_slide__image_file_name	tcga-a1-a0se-01a-01-bs1.bc41fb6d-f6a5-495c-b429-80d289f0bda1.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	2
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	7
biospecimen_slide__percent_stromal_cells	13
biospecimen_slide__percent_tumor_cells	80
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	bottom
biospecimen_tumor_sample__bcr_patient_barcode	tcga-a1-a0se
biospecimen_tumor_sample__bcr_patient_uuid	c397e6c2-ba3a-4f5e-a258-c140611192fe
clinical_patient__age_at_diagnosis	56
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0 (i-)
clinical_patient__ajcc_pathologic_tumor_stage	stage i
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t1c
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-a1-a0se
clinical_patient__bcr_patient_uuid	c397e6c2-ba3a-4f5e-a258-c140611192fe
clinical_patient__birth_days_to	-20717
clinical_patient__cent17_copy_number	2
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	3+
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	80-89%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2010-12-6
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1
clinical_patient__her2_copy_number	2
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histologic_diagnosis_other	invasive ductal and lobular carcinoma
clinical_patient__histological_type	mixed histology (please specify)
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8522/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2005
clinical_patient__last_contact_days_to	1321
clinical_patient__lymph_nodes_examined_count	8
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__patient_id	a0se
clinical_patient__pr_positivity_ihc_intensity_score	3+
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	90-99%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	a1
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A1-A0SE-01A-11D-A099-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A1-A0SE-01A-11D-A099-09.bed.meta
manually_curated__id	tcga-a1-a0se-01a-11d-a099-09
manually_curated__md5sum	0f8475739dbc3d322fc35414d7b9ac27
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	0539776c-3943-41d0-972c-8dc833a603e5
manually_curated__tumor_tag	brca
